GSE156761 dopamine neuron 0 v 5 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE156761_dopamine_neuron_0_v_5_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE156761_dopamine_neuron_0_v_5_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE156761_dopamine_neuron_0_v_5_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE156761_dopamine_neuron_0_v_5_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

GNAS complex locus

Gene

secreted frizzled related protein 1

Gene

paternally expressed 10

Gene

3-hydroxy-3-methylglutaryl-CoA synthase 1

Gene

activated leukocyte cell adhesion molecule

Gene

adipogenesis regulatory factor

Gene

stearoyl-CoA desaturase

Gene

tubulin beta 2A class IIa

Gene

heat shock protein family A (Hsp70) member 1A

Gene

transforming growth factor beta induced

  • Gene

    GNAS complex locus


  • Gene

    secreted frizzled related protein 1


  • Gene

    paternally expressed 10


  • Gene

    3-hydroxy-3-methylglutaryl-CoA synthase 1


  • Gene

    activated leukocyte cell adhesion molecule


  • Gene

    adipogenesis regulatory factor


  • Gene

    stearoyl-CoA desaturase


  • Gene

    tubulin beta 2A class IIa


  • Gene

    heat shock protein family A (Hsp70) member 1A


  • Gene

    transforming growth factor beta induced

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.